Deals channel feed – Endpoints News

Deals channel feed

Updated: Otsuka buys out small molecule drug discovery startup Jnana and its rare disease pill for $800M cash

10 months ago

Biosecure lawmakers tell trade groups that China studies are a new focus

10 months ago

Behind Boehringer’s up to $1.3B Nerio deal is a budding cancer pipeline and aim to ‘leapfrog AbbVie’

10 months ago

Boehringer Ingelheim buys oncology biotech for up to $1.3B

10 months ago

NewAmsterdam succeeds in the first of three key pivotal studies, providing hope to a troubled cardio class

10 months ago

Updated: GSK and Flagship to create up to 10 vaccines, medicines across respiratory and immunology

10 months ago

Ipsen pays Day One $111M upfront for ex-US rights to pediatric brain tumor drug

10 months ago

In a tough market, private biotechs pursue IPOs and buyouts at the same time

10 months ago

Novartis pays $150M upfront, including $25M in equity, for Dren Bio’s bispecifics

10 months ago

BioNTech signs 3D printing deal to develop oral RNA drugs

10 months ago

AstraZeneca signs preclinical EGFR drug deal with antibody biotech

10 months ago

Health tech startup Commure bets on AI for medical notes in $139M deal

10 months ago

Agilent Technologies to acquire CDMO Biovectra for $925M

10 months ago

HI-Bio dishes on motivations for Biogen buyout, citing desire to move fast

10 months ago

Roivant recently sold one spinout for billions. Is Priovant next?

10 months ago

Corrected: Lilly upped its offer for Morphic by $11 per share, documents show

10 months ago

J&J ditches epilepsy development with Addex, blindsiding 20-year partner

10 months ago

‘Search mode’: Human challenge trial company looks to buy small CROs

10 months ago

Genentech parts ways with Relay Therapeutics on SHP2 after other pharma exits

10 months ago

Sionna licenses clinical-stage cystic fibrosis assets from AbbVie shortly after large Series C

10 months ago

After last year's ImmunoGen pact, Vertex finds another conditioning agent partner in Orum

10 months ago

Two healthcare SPACs go public, with several more on the hunt for deals

10 months ago

Ten biotech executives who reaped the biggest M&A windfalls, netting $40M+ exit packages

10 months ago

Ipsen takes on another ADC, this time from a China-based biotech

10 months ago

First page Previous page 12 13 141516 17 18 Next page Last page